Abstract：
:Moraxella catarrhalis is a human-specific commensal of the respiratory tract and an opportunistic pathogen. It is one of the leading cause of otitis media in children and of acute exacerbations in patients with chronic obstructive pulmonary disease, resulting in significant morbidity and economic burden. Vaccines and new immunotherapeutic strategies to treat this emerging pathogen are needed. Complement is a key component of innate immunity that mediates the detection, response, and subsequent elimination of invading pathogens. Many pathogens including M. catarrhalis have evolved complement evasion mechanisms, which include the binding of human complement inhibitors such as C4b-binding protein (C4BP) and Factor H (FH). Inhibiting C4BP and FH acquisition by M. catarrhalis may provide a novel therapeutic avenue to treat infections. To achieve this, we created two chimeric proteins that combined the Moraxella-binding domains of C4BP and FH fused to human immunoglobulin Fcs: C4BP domains 1 and 2 and FH domains 6 and 7 fused to IgM and IgG Fc, respectively. As expected, FH6-7/IgG displaced FH from the bacterial surface while simultaneously activating complement via Fc-C1q interactions, together increasing pathogen elimination. C4BP1-2/IgM also increased serum killing of the bacteria through enhanced complement deposition, but did not displace C4BP from the surface of M. catarrhalis. These Fc fusion proteins could act as anti-infective immunotherapies. Many microbes bind the complement inhibitors C4BP and FH through the same domains as M. catarrhalis, therefore these Fc fusion proteins may be promising candidates as adjunctive therapy against many different drug-resistant pathogens.
journal_name
Front Immunoljournal_title
Frontiers in immunologyauthors
Laabei M,Colineau L,Bettoni S,Maziarz K,Ermert D,Riesbeck K,Ram S,Blom AMdoi
10.3389/fimmu.2020.02122subject
Has Abstractpub_date
2020-09-02 00:00:00pages
2122issn
1664-3224journal_volume
11pub_type
杂志文章abstract：:Memory CD8+ T cells have long been considered a promising population for adoptive cell therapy (ACT) due to their long-term persistence and robust re-stimulatory response. NIH3T3 is an immortalized mouse embryonic fibroblast cell line. We report that NIH3T3-conditioned medium (CM) can augment effector functions of CTL...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2019.00761
更新日期：2019-04-11 00:00:00
abstract：:Inflammation is a complex process which is highly conserved among species. Inflammation occurs in response to injury, infection, and cancer, as an allostatic mechanism to return the tissue and to return the organism back to health and homeostasis. Excessive, or chronic inflammation is associated with numerous diseases...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2019.01591
更新日期：2019-07-09 00:00:00
abstract：:Immune checkpoint blockade therapy has prevailed for several types of cancer; however, its effectiveness as a single therapy is still limited. In principle, dendritic cells (DCs) should be able to control the post-therapy immune response, in particular since they can link the two major arms of the immune system: innat...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2017.00886
更新日期：2017-07-31 00:00:00
abstract：:Hematopoietic stem cells (HSCs) are quiescent cells with self-renewal capacity and the ability to generate all mature blood cells. HSCs normally reside in specialized niches in the bone marrow that help maintain their quiescence and long-term repopulating activity. There is emerging evidence that certain cytokines ind...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2013.00204
更新日期：2013-07-19 00:00:00
abstract：:NLRC5 is a member of the NLR family that acts as a transcriptional activator of MHC class I genes. In line with the function of several related NLR proteins in innate immune responses, there is, however, also ample evidence that NLRC5 contributes to innate and adaptive immune responses beyond the regulation of MHC cla...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2017.00150
更新日期：2017-02-17 00:00:00
abstract：:Despite continuous exposure and development of specific immunity, Staphylococcus aureus (Sa) remains one of the leading causes of severe infections worldwide. Although innate immune defense mechanisms are well understood, the role of the T cell response has not been fully elucidated. Here, we demonstrate that Sa and o...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2020.581713
更新日期：2020-09-30 00:00:00
abstract：:Infectious diseases are still a significant cause of morbidity and mortality worldwide. Despite the progress in drug development, the occurrence of microbial resistance is still a significant concern. Alternative therapeutic strategies are required for non-responding or relapsing patients. Chimeric antigen receptor (C...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2019.02711
更新日期：2019-11-21 00:00:00
abstract：:CD28:CD80/86 pathway costimulation blockade (CoB) with the CD80/86-specific fusion protein CTLA4-Ig prevents T cell-mediated allograft rejection in mice. However, in humans, transplantation with CoB has been hampered by CoB-resistant rejection (CoBRR). CoBRR has been attributed in part to pathogen-driven T cell repert...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2018.01371
更新日期：2018-06-15 00:00:00
abstract：:Lipid metabolism plays a key role in many cellular processes. We show here that regulatory T cells have enhanced lipid storage within subcellular lipid droplets (LD). They also express elevated amounts of both isoforms of diacylglycerol acyl transferase (DGAT1 & 2), enzymes required for the terminal step of triacylgly...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2019.01860
更新日期：2019-08-13 00:00:00
abstract：:Worldwide, breast cancer (BC) is the leading cause of cancer death among women. For many patients the most effective treatment is a resection surgery that removes the tumor. Within this subset, patients sometimes receive chemotherapy treatment (CT) prior to surgery aiming to reduce tumor size in order to preserve heal...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2020.01413
更新日期：2020-07-09 00:00:00
abstract：Background:A plurality of neurological syndromes is associated with autoantibodies against neural antigens relevant for diagnosis and therapy. Identification of these antigens is crucial to understand the pathogenesis and to develop specific immunoassays. Using an indirect immunofluorescence assay (IFA)-based approach ...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2018.01447
更新日期：2018-07-09 00:00:00
abstract：:CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic cells (DC). mCD83 regulates maturation, activation and homeostas...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2019.01312
更新日期：2019-06-07 00:00:00
abstract：:Pentraxin 3 (PTX3) is a soluble pattern recognition receptor that is a humoral component of the innate immune system. It interacts with pathogenic moieties, infected and dying host cells and facilitates their removal through activation of appropriate innate and adaptive mechanisms. PTX3 is secreted by a diverse variet...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2013.00127
更新日期：2013-05-31 00:00:00
abstract：:The induction and modulation of the immune response to vaccination can be rationally designed by combining different vaccine formulations for priming and boosting. Here, we investigated the impact of heterologous prime-boost approaches on the vaccine-specific cellular and humoral responses specific for a mycobacterial...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2018.00380
更新日期：2018-03-12 00:00:00
abstract：:The survival of helminths in the host over long periods of time is the result of a process of adaptation or dynamic co-evolution between the host and the parasite. However, infection with helminth parasites causes damage to the host tissues producing the release of danger signals that induce the recruitment of various...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2018.00664
更新日期：2018-04-04 00:00:00
abstract：:Objective: Intestinal Behcet's disease (iBD) is an autoimmune disorder diagnosed by typical intestinal ulcers and systemic Behcet's disease (BD) manifestations. Haploinsufficiency of A20 (HA20) is a recently described autoinflammatory disease with a phenotype resembling BD, caused by heterozygous loss-of-function muta...
journal_title：Frontiers in immunology
pub_type：
doi：10.3389/fimmu.2020.01414
更新日期：2020-07-03 00:00:00
abstract：:[This corrects the article DOI: 10.3389/fimmu.2020.562282.]. ...
journal_title：Frontiers in immunology
pub_type： 已发布勘误
doi：10.3389/fimmu.2020.625157
更新日期：2020-12-16 00:00:00
abstract：:The germinal center reaction is an important target for modulating antibody responses. Antibody production from germinal centers is regulated by a negative feedback mechanism termed antibody feedback. By imposing antibody feedback, germinal centers can interact and regulate the output of other germinal centers. Using ...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2019.02116
更新日期：2019-09-06 00:00:00
abstract：:DNA vaccines have great potential to control infectious disease, particularly those caused by intracellular organisms. They are inexpensive to produce and can be quickly modified to combat emerging infectious threats, but often fail to generate a strong immunologic response limiting enthusiasm for their use in humans ...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2019.02411
更新日期：2019-10-11 00:00:00
abstract：:Over the last decade, the acceleration in the clinical use of mesenchymal stromal cells (MSCs) has been nothing short of spectacular. Perhaps most surprising is how little we know about the "MSC product." Although MSCs are being delivered to patients at an alarming rate, the regulatory requirements for MSC therapies (...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2019.01112
更新日期：2019-05-16 00:00:00
abstract：:Inflammasomes are intracellular protein complexes of pattern recognition receptors and caspase-1, with essential functions in regulating inflammatory responses of macrophages and dendritic cells. The primary role of inflammasomes is to catalyze processing and secretion of pro-inflammatory cytokines IL-1β and IL-18. Re...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2018.02188
更新日期：2018-09-25 00:00:00
abstract：:Objectives: This study, developed within the Innovative Medicines Initiative Joint Undertaking project PRECISESADS framework, aimed at functionally characterize the monocyte subsets in RA patients, and analyze their involvement in the increased CV risk associated with RA. Methods: The frequencies of monocyte subpopula...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2019.01111
更新日期：2019-05-21 00:00:00
abstract：:Cytotoxic T lymphocytes and NK cells play an important role in eliminating malignant tumor cells and the number and activity of tumor-infiltrating T cells represent a good marker for tumor prognosis. Based on these findings, immunotherapy, e.g., checkpoint blockade, has received considerable attention during the last ...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2017.00248
更新日期：2017-03-08 00:00:00
abstract：Background:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is spreading worldwide. Measuring the prevention and control of the disease has become a matter requiring urgent focus. Objective:Based on coronavirus disease 2019 (COVID-19) clinical data from Wuhan, we conducted an in-depth analysis to...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2020.02160
更新日期：2020-09-02 00:00:00
abstract：:Paclitaxel is a chemotherapeutic drug commonly used to treat different types of cancer. In addition to its antitumor effect, paclitaxel is also known to promote Toll-like receptor (TLR) 4-dependent inflammatory responses, which may lower its chemotherapeutic efficacy. However, it remains unclear whether paclitaxel is ...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2019.01108
更新日期：2019-05-16 00:00:00
abstract：:People are constantly exposed to airborne fungal spores, including Aspergillus fumigatus conidia that can cause life-threatening conditions in immunocompromised patients or acute exacerbations in allergics. However, immunocompetent hosts do not exhibit mycoses or systemic inflammation, due to the sufficient but not ex...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2020.00298
更新日期：2020-02-25 00:00:00
abstract：:Behavioral comorbidities (depression, anxiety, fatigue, cognitive disturbances, and neuropathic pain) are prevalent in cancer patients and survivors. These mental and neurological health issues reduce quality-of-life, which is a significant societal concern given the increasing rates of long-term survival after variou...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2018.01195
更新日期：2018-06-07 00:00:00
abstract：:Vaccination with CD1d-binding glycolipid adjuvants and co-administered protein, lipid, and carbohydrate antigens leads to invariant natural killer T (NKT) cell-dependent enhancement of protective B cell responses. NKT cell activation boosts the establishment of protein antigen-specific B cell memory and long-lived pla...
journal_title：Frontiers in immunology
pub_type： 杂志文章,评审
doi：10.3389/fimmu.2018.00305
更新日期：2018-02-22 00:00:00
abstract：:Migration of human plasmablast to the bone marrow is essential for the final differentiation of plasma cells and maintenance of effective humoral immunity. This migration is controlled by CXCL12/CXCR4-mediated activation of the protein kinase AKT. Herein, we show that the CXCL12-induced migration of human plasmablasts...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2018.01742
更新日期：2018-07-27 00:00:00
abstract：:The clinical experience gathered throughout the years has raised awareness of primary immunodeficiency diseases (PIDD). T cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC) assays for thymic and bone marrow outputs measurement have been widely implemented in newborn screenin...
journal_title：Frontiers in immunology
pub_type： 杂志文章
doi：10.3389/fimmu.2020.01411
更新日期：2020-07-16 00:00:00
